v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
| Column | Value |
|---|---|
| Trial registration number | NCT05126602 |
|
Full text link
Last imported at : Nov. 19, 2021, 7:30 p.m. Source : ClinicalTrials.gov |
|
|
First author
Last imported at : Nov. 19, 2021, 7:30 p.m. Source : ClinicalTrials.gov |
|
|
Contact
Last imported at : Nov. 19, 2021, 7:30 p.m. Source : ClinicalTrials.gov |
Not reported |
|
Registration date
Last imported at : Nov. 19, 2021, 7:30 p.m. Source : ClinicalTrials.gov |
2021-11-19 |
|
Recruitment status
Last imported at : Nov. 19, 2021, 7:30 p.m. Source : ClinicalTrials.gov |
Completed |
|
Study design
Last imported at : Nov. 19, 2021, 7:30 p.m. Source : ClinicalTrials.gov |
RCT |
|
Allocation
Last imported at : Nov. 19, 2021, 7:30 p.m. Source : ClinicalTrials.gov |
Randomized |
|
Design
Last imported at : Nov. 19, 2021, 7:30 p.m. Source : ClinicalTrials.gov |
Parallel |
|
Masking
Last imported at : Nov. 19, 2021, 7:30 p.m. Source : ClinicalTrials.gov |
Blind label |
|
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
single-center |
|
Study aim
Last imported at : Nov. 19, 2021, 7:30 p.m. Source : ClinicalTrials.gov |
Treatment |
|
Inclusion criteria
Last imported at : Nov. 19, 2021, 7:30 p.m. Source : ClinicalTrials.gov |
inclusion criteria: belongs to moderate case diagnosed using pcr test showing a vitamin d deficiency (<30 ng/dl). exclusion criteria pregnant or doing breastfeeding patient under specific medication (tuberculosis, or hiv, or malignancy) or undergo hemodialysis receive vitamin d supplementation prior to allocation. tested negative less than 5 days after receiving vitamin d creatinine >2,0 mg/dl blood calcium >10,5 mg/dl. ventilated hypersensitive to vitamin d consistent desaturation <85% with oxygen supplementation and require high-flow nasal cannula (hfnc)/extracorporeal membrane oxygenation (ecmo) via a ventilator. refuse to attend blood examination for follow up |
|
Exclusion criteria
Last imported at : Nov. 19, 2021, 7:30 p.m. Source : ClinicalTrials.gov |
None |
|
Number of arms
Last imported at : Nov. 19, 2021, 7:30 p.m. Source : ClinicalTrials.gov |
2 |
|
Funding
Last imported at : Nov. 19, 2021, 7:30 p.m. Source : ClinicalTrials.gov |
Bumi Herman |
|
Inclusion age min
Last imported at : Nov. 19, 2021, 7:30 p.m. Source : ClinicalTrials.gov |
18 |
|
Inclusion age max
Last imported at : Nov. 19, 2021, 7:30 p.m. Source : ClinicalTrials.gov |
100 |
|
Countries
Last imported at : Nov. 19, 2021, 7:30 p.m. Source : ClinicalTrials.gov |
Indonesia |
|
Type of patients
Last imported at : Nov. 19, 2021, 7:30 p.m. Source : ClinicalTrials.gov |
Moderate/severe disease at enrollment |
|
Severity scale
Last imported at : Nov. 19, 2021, 7:30 p.m. Source : ClinicalTrials.gov |
4: Moderate/severe disease at enrollment |
|
Total sample size
Last imported at : Nov. 19, 2021, 7:30 p.m. Source : ClinicalTrials.gov |
60 |
|
primary outcome
Last imported at : Nov. 19, 2021, 7:30 p.m. Source : ClinicalTrials.gov |
Clinical Recovery Time;D-Dimer;Length of Stay;Neutrophil-Lymphocyte Ratio (NLR) in blood;PCR Conversion time;Platelet to Lymphocyte Ratio / PLR in blood;Total Lymphocyte Count (TLC) in blood |
|
Notes
Last imported at : Nov. 19, 2021, 7:30 p.m. Source : ClinicalTrials.gov |
None |
|
Phase
Last imported at : Nov. 19, 2021, 7:30 p.m. Source : ClinicalTrials.gov |
Not reported |
|
Arms
Last imported at : Nov. 19, 2021, 7:30 p.m. Source : ClinicalTrials.gov |
[{"arm_notes": "1000 IU", "treatment_id": 1371, "treatment_name": "Vitamin d3", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "5000 IU ", "treatment_id": 1371, "treatment_name": "Vitamin d3", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}] |